Laura A. van de Pol

Learn More
The Development of Screening Guidelines and Clinical Criteria of Predementia Alzheimer’s Disease (DESCRIPA) multicenter study enrolled patients with MCI or subjective cognitive complaints (SUBJ), a part of whom underwent optional brain perfusion SPECT. These patients were classified as SUBJ (n = 23), nonamnestic MCI (naMCI; n = 17) and amnestic MCI (aMCI; n(More)
Our aim was to compare the predictive accuracy of 4 different medial temporal lobe measurements for Alzheimer's disease (AD) in subjects with mild cognitive impairment (MCI). Manual hippocampal measurement, automated atlas-based hippocampal measurement, a visual rating scale (MTA-score), and lateral ventricle measurement were compared. Predictive accuracy(More)
Background: Hippocampal atrophy on MRI is an early characteristic of Alzheimer’s disease (AD). However, hippocampal atrophy may also occur in other dementias, like frontotemporal lobar degeneration (FTLD). Aim: To investigate hippocampal atrophy on MRI in FTLD and its three clinical subtypes, in comparison to AD, using volumetry and a visual rating scale.(More)
1Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, the Netherlands; 2Department of Psychiatry and Neuropsychology, University of Maastricht, the Netherlands; 3IRCCS San Giovanni, Laboratory of Epidemiology and Neuroimaging, Brescia , Italy; 4Aristotle University of Thessaloniki, Memory and Dementia Centre, 3rd Department of Neurology,(More)
  • 1